Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.
Lisa A. Kachnic
Disclosure not yet available
Kathryn A. Winter
Disclosure not yet available
Robert J. Myerson
Disclosure not yet available
Michael D. E. Goodyear
Disclosure not yet available
John Willins
Disclosure not yet available
Jacqueline Esthappan
Disclosure not yet available
Michael G. Haddock
Disclosure not yet available
Marvin Rotman
Disclosure not yet available
Parag J. Parikh
Disclosure not yet available
Christopher G. Willett
Disclosure not yet available